Subgroup analysis and covariate adjustment in randomized clinical trials of traumatic brain injury: A systematic review

Neurosurgery

Volumn 57, Issue 6, 2005, Pages 1244-1253

  Hernández, Adrían V ^a   Steyerberg, Ewout W ^a   Taylor, Gillian S ^b   Marmarou, Anthony ^c   Habbema, J Dik F ^a   Maas, Andrew I R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute traumatic brain injury; CONSORT; Covariate adjustment; Randomized clinical trials; Reporting; Subgroup analysis; Systematic review

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; DEXAMETHASONE; MANNITOL; METHYLPREDNISOLONE; NIMODIPINE; TROMETAMOL;

ANALYTICAL PARAMETERS; CLINICAL PROTOCOL; CLINICAL TRIAL; COVARIATE ADJUSTMENT; CRANIOTOMY; DISEASE SEVERITY; GLASGOW OUTCOME SCALE; HUMAN; HYPERBARIC OXYGEN; INFORMATION PROCESSING; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; REVIEW; SECONDARY ANALYSIS; STATISTICAL ANALYSIS; SUBGROUP ANALYSIS; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

BRAIN INJURIES; GLASGOW OUTCOME SCALE; HUMANS; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 29244476263     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000186039.57548.96     Document Type: Review

References (51)

1. Altman DG, Schultz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T: CONSORT GROUP (Consolidated Standards of Reporting Trials): The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 134:663-694, 2001.
2. Assmann SF, Pocock SJ, Enos LE, Kasten LE: Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 355:1064-1069, 2000.
3. Bailey I, Bell A, Gray R, Gullan R, Heiskanan O, Marks PV, Marsh H, Mendelow DA, Murray G, Ohman J, Quaghebeur G, Sinar J, Skene A, Teasdale G, Waters A: A trial of the effect of nimodipine on outcome after head injury. Acta Neurochir (Wien) 110:97-105, 1991.
4. Bayir H, Clark RS, Kochanek PM: Promising strategies to minimize secondary brain injury after head trauma. Crit Care Med 31[Suppl]:S112-S117, 2003.
5. Braakman R, Scheuten HJ, Blaauw-van Dishoeck M, Minderhoud JM: Megadose steroids in severe head injury: Results of a prospective double blind clinical trial. J Neurosurg 58:326-330, 1983.
6. Brookes ST, Whitley E, Egger M, Davey Smith G, Mulheran PA, Peters TJ: Subgroup analyses in randomized trials: Risks of subgroup-specific analyses: Power and sample size for the interaction test. J Clin Epidemiol 57:229-236, 2004.
7. Bullock MR, Merchant RE, Choi SC, Gilman CB, Kreutzer JS, Marmarou A, Teasdale GM: Outcome measures for clinical trials in neurotrauma. Neurosurg Focus 13, 2002. http://www.aans.org/education/journal/neurosurgical/july02/13-1- nsf-toc.asp.
8. Chan A, Hróbjartsson A, Haahr MT, Gótzsche PC, Altman DG: Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published results. JAMA 291:2457-2465, 2004.
9. Choi SC: Sample size in clinical trials with dichotomous endpoints: Use of covariables. J Biopharm Stat 8:367-375, 1998.
10. Choi SC, Bullock R: Design and statistical issues in multicenter trials of severe head injury. Neurol Res 23:190-192, 2001.
11. Choi SC, Clifton GL, Marmarou A, Miller ER: Misclassification and treatment effect on primary outcome measures in clinical trials of severe neurotrauma. J Neurotrauma 19:17-22, 2002.
12. Clifton GL, Miller ER, Choi SC, Levin HS, McCauley S, Smith KR, Muizelaar JP, Wagner FC, Marion DW, Luerssen TG, Chesnut RM, Schwartz M: Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 344:556-563, 2001.
13. Cook DI, Gebski VJ, Keech AC: Subgroup analysis in clinical trials. Med J Aust 180:289-291, 2004.
14. Cooper DJ, Myles PS, McDermott FT, Murray LJ, Laidlaw J, Cooper G, Tremayne AB, Bernard SS, Ponsford J: For the HTS Study Investigators: Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: A randomized controlled trial. JAMA 291: 1350-1357, 2004.
15. Cruz J, Minoja G, Okuchi K: Improving clinical outcomes from acute subdural hematomas with the emergency preoperative administration of high doses of mannitol: A randomized trial. Neurosurgery 49:864-871, 2001.
16. Cruz J, Minoja G, Okuchi K: Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupilary widening: A randomized trial. Neurosurgery 51:628-638, 2002.
17. Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I: Size and quality of randomised controlled trials in head injury: Review of published studies. Br Med J 320:1308-1311, 2000.
18. Doppenberg EM, Choi SC, Bullock R: Clinical trials in traumatic brain injury: Lessons for the future. J Neurosurg Anesthesiol 16:87-94, 2004.
19. Dutton RP, MacCunn M: Traumatic brain injury. Curr Opin Crit Care 9:503-509, 2003.
20. Gaab MR, Trost HA, Alcantara A, Karimi-Nejad A, Moskopp D, Schultheiss R, Bock WJ, Piek J, Klinge H, Scheil F, Osterwald P, Samii M, Brawanski A, Meixensberger J, Schurmann K, Schubert R, Arnold H, Kehler U, Deisenroth K, Benker G, Vester JC, Dietz H: "Ultrahigh" dexamethasone in acute brain injury: Results from a prospective randomized double-blind multicenter trial (GUDHIS). Zentralbl Neurochir 55:135-143, 1994.
21. Grumme T, Baethmann A, Kolodziejczyk D, Krimmer J, Fischer M, Eisenhart Rothe B, Pelka R, Bennefeld H, Pollauer E, Kostron H, Leheta F, Necek S, Neeser G, Sachsenheimer W, Sommerauer J, Verhoeven F: Treatment of patients with severe head injury by triamcinolone: A prospective, controlled multicenter clinical trial of 396 cases. Res Exp Med (Berl) 195:217-229, 1995.
22. Harders A, Kakarieka A, Braakman R: Traumatic subarachnoid hemorrhage and its treatment with nimodipine. German tSAH Study Group. J Neurosurg 85:82-89, 1996.
23. Harris C, DiRusso S, Sullivan T, Benzil DL: Mortality risk after head injury increases at 30 years. J Am Coll Surg 197:711-716, 2003.
24. Hauck WW, Anderson S, Marcus SM: Should we adjust for covariates in non-linear regression analyses of randomized trials? Control Clin Trials 19:248-256, 1998.
25. Hernández AV, Steyerberg EW, Habbema JDF: Clinical trials with dichotornous end-points: Covariate adjustment increased power and potentially reduces sample size. J Clin Epidemiol 57:454-460, 2004.
26. th Biannual Conference of the European Society of Medical Decision Making, Rotterdam, The Netherlands. June 6-8, 2004.
27. Hukkelhoven CW, Steyerberg EW, Farace E, Habbema JD, Marshall LF, Maas AI: Regional differences in patient characteristics, case management, and outcomes in traumatic brain injury: Experience from tirilazad trials. J Neurosurg 97:549-557, 2002.
28. Hukkelhoven CW, Steyerberg EW, Maas AI: Quality of randomised controlled trials in head injury. Br Med J 321:704, 2000.
29. Hukkelhoven CW, Steyerberg EW, Rampen AJ, Farace E, Habbema JD, Marshall LF, Murray GD, Maas AI: Patient age and outcome following severe traumatic brain injury: An analysis of 5600 patients. J Neurosurg 99:666-673, 2003.
30. Jennett B: Epidemiology of head injury. J Neurol Neurosurg Psychiatry 60:362-369, 1996.
31. Lu LQ, Jiang JY, Yu MK, Hou LJ, Chen ZG, Zhang GJ, Zu C: Standard large trauma craniotomy for severe traumatic brain injury. Chin J Traumatol 6:302-304, 2003.
32. Maas AI, Steyerberg EW, Murray GD, Bullock R, Baethmann A, Marshall LF, Teasdale GM: Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations. Neurosurgery 44:1286-1298, 1999.
33. Machado SG, Murray GD, Teasdale GM: Evaluation of designs for clinical trials of neuroprotective agents in head injury. J Neurotrauma 16:1131-1138, 1999.
34. Marshall LF, Maas AIR, Marshall SB, Bricolo A, Fearnside M, Iannotti F, Klauber MR, Lagarrigue J, Lobato R, Persson L, Pickard JD, Piek J, Servadei F, Wellis GN, Morris GF, Means ED, Musch B: A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J Neurosurg 89:519-525, 1998.
35. Masson F: Epidemiology of severe cranial injuries [in French]. Ann Fr Anesth Reanim 19:261-269, 2000.
36. Morris GF, Bullock R, Marshall SB, Marmarou A, Maas A, Marshall LF: Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: Results of two phase III clinical trials. The Selfotel Investigators. J Neurosurg 91:737-743, 1999.
37. Mosenthal AC, Lavery RF, Addis M, Kaul S, Ross S, Marburger R, Deitch EA, Livingston DH: Isolated traumatic brain injury: Age is an independent predictor of mortality and early outcome. J Trauma 52:907-911, 2002.
38. Moyé LA, Deswal A: Trials within trials: Confirmatory subgroup analyses in controlled clinical experiments. Control Clin Trials 22:605-619, 2001.
39. Narayan RK, Michel ME: The Clinical Trials in Head Injury Study Group: Clinical trials in head injury. J Neurotrauma 19:503-557, 2002.
40. Reinert MM, Bullock R: Clinical trials in head injury. Neurol Res 21:330-338, 1999.
41. Rockswold GL, Ford SE, Anderson DC, Bergman TA, Sherman RE: Results of a prospective randomized trial for treatment of severely brain-injured patients with hyperbaric oxygen. J Neurosurg 76:929-934, 1992.
42. Saul TG, Ducker TB, Salcman M, Carro E: Steroids in severe head injury: A prospective randomized clinical trial. J Neurosurg 54:596-600, 1981.
43. Simes RJ, Gebski VJ, Keech AC: Subgroup analysis: Application to individual patient decisions. Med J Aust 180:467-469, 2004.
44. The European Agency for the Evaluation of Medicinal Products Committee for Proprietary Medicinal Products (CPMP): Points to consider on adjustment for baseline characteristics. Document CPMP/EWP/2863/99, EMEA, London, May 22, 2003.
45. The European Study Group on Nimodipine in Severe Head Injury: A multicenter trial of the efficacy of nimodipine on outcome after severe head injury. J Neurosurg 80:797-804, 1994.
46. Vranos G, Tatsioni A, Polyzoidis K, Ioannidis JP: Randomized trials of neurosurgical interventions: A systematic appraisal. Neurosurgery 55:18-26, 2004.
47. Wilson JT: Assessing outcome in head injury trials. Curr Pharm Des 7:1537-1552, 2001.
48. Wolf AL, Levi L, Marmarou A, Ward JD, Muizelaar PJ, Choi S, Young H, Rigamonti D, Robinson WL: Effect of THAM upon outcome in severe head injury: A randomized prospective clinical trial. J Neurosurg 78:54-59, 1993.
49. Young B, Runge JW, Waxman KS, Harrington T, Wilberger J, Muizelaar JP, Boddy A, Kupiec JW: Effects of pegorgotein on neurologic outcome of patients with severe head injury: A multicenter, randomized controlled trial. JAMA 276:538-543, 1996.
50. Yusuf S, Wittes J, Probstfield J, Tyroler HA: Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 266:93-98, 1991.
51. Zhi D, Zhang S, Lin X: Study on therapeutic mechanism and clinical effect of mild hypothermia in patients with severe head injury. Surg Neurol 59:381-385, 2003.